The redness score further demonstrated that the HTR3A antagonist TPS significantly inhibited the L5-induced rosacea-like dermatitis, while TPS itself did not cause any changes in skin manifestations (Figure 5B). This evidence concerns the gene HTR3A and skin disorder.